Campion Asset Management’s Pfizer PFE Stock Holding History

Campion Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,099	Closed	-$234K	–	91
2024 Q3	$234K	Sell	8,099 -570	-7%	-$16.6K	0.17%	87
2024 Q2	$243K	Sell	8,669 -4,119	-32%	-$113K	0.19%	86
2024 Q1	$355K	Sell	12,788 -477	-4%	-$13.2K	0.27%	70
2023 Q4	$382K	Sell	13,265 -1,190	-8%	-$36K	0.32%	63
2023 Q3	$479K	Hold	14,455	–	–	0.44%	50
2023 Q2	$530K	Buy	14,455 +260	+2%	+$10.1K	0.47%	46
2023 Q1	$579K	Sell	14,195 -75	-0.5%	-$3.24K	0.55%	40
2022 Q4	$731K	Sell	14,270 -335	-2%	-$16.1K	0.72%	30
2022 Q3	$639K	Hold	14,605	–	–	0.68%	33
2022 Q2	$766K	Hold	14,605	–	–	0.76%	30
2022 Q1	$756K	Hold	14,605	–	–	0.64%	34
2021 Q4	$862K	Hold	14,605	–	–	0.72%	30
2021 Q3	$628K	Hold	14,605	–	–	0.56%	36
2021 Q2	$572K	Sell	14,605 -1,689	-10%	-$65.7K	0.47%	38
2021 Q1	$590K	Buy	+16,294	New	+$579K	0.45%	41

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Campion Asset Management's PFE Position: Q4 2024 in Review

Campion Asset Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,099 shares — an estimated $234K sold.

Campion Asset Management first reported a position in PFE in Q1 2021 and held it in 15 quarters. The position peaked at $862K in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Campion Asset Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Campion Asset Management sold 8,099 Pfizer shares in Q4 2024, an estimated $234K.
Campion Asset Management first reported a position in Pfizer in Q1 2021 and held it in 15 quarters.
Campion Asset Management's Pfizer position peaked at $862K in Q4 2021.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Campion Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.